ASX:EZZ EZZ Life Science (EZZ) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free EZZ Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield4.19%Price TargetN/A Stock AnalysisStock Analysis Get EZZ Life Science alerts: Email Address Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. About EZZ Life ScienceEZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand. The company also offers its products online. EZZ Life Science Holdings Limited was incorporated in 2015 and is based in Silverwater, Australia.Read More Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. EZZ Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive EZZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EZZ Life Science and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:EZZ CUSIPN/A CIKN/A Webezzlife.com.au Phone61 2 9160 2305FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.08 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.47 million Net Margins7.94% Pretax MarginN/A Return on Equity24.87% Return on Assets15.56% Debt Debt-to-Equity Ratio1.99 Current Ratio3.92 Quick Ratio4.53 Sales & Book Value Annual Sales$43.73 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.36 per share Price / BookN/AMiscellaneous Outstanding Shares42,700,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.61 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Mark QinCo-founder, COO, CEO & Executive DirectorAnthony GuarnaChief Financial OfficerMs. Natalie Climo L.L.B.Company SecretaryKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersGlenn CrossBought 26,000 shares on 10/11/2023Total: $16,900.00 ($0.65/share) EZZ Stock Analysis - Frequently Asked Questions How often does EZZ Life Science pay dividends? What is the dividend yield for EZZ Life Science? EZZ Life Science declared a Final dividend on Wednesday, October 25th. Stockholders of record on Thursday, December 7th will be given a dividend of 0.01 per share on Thursday, December 7th. This represents a dividend yield of 1.59%. The ex-dividend date of this dividend is Sunday, October 29th. This is a boost from the stock's previous Final dividend of A$0.01. Read our dividend analysis for EZZ. Is EZZ Life Science a good dividend stock? EZZ Life Science (ASX:EZZ) pays an annual dividend of A$0.02 per share and currently has a dividend yield of 4.19%. EZZ has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 25.00%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for EZZ. This page (ASX:EZZ) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EZZ Life Science Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.